Efficacy and safety of erythropoietic agents in anaemic patients with lung cancer (LC) Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010
Chemotherapy induced neutropenia in lung cancer patients: a single centre study Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009
Antibiotic prophylaxis in chemotherapy-induced neutropenia in lung cancer patients Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011
The effectiveness of pegfilgrastim in preventing leucopenia in patients with lung cancer under chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 77s Year: 2005
Efficiency of erythropoiesis-stimulating agents (ESA) in the treatment of chemotherapy-induced anemia in patients with lung cancer (LC) Source: International Congress 2015 – Lung cancer therapy: clinical trials Year: 2015
Efficacy of darbepoietin alfa in anemia developed during chemotherapy for lung cancer Source: Annual Congress 2008 - Treatment of thoracic tumours Year: 2008
The incidence of neutropenia in patients undergoing outpatient chemotherapy for lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 755s Year: 2006
Lung cancer patients hospitalized for febrile neutropenia: A retrospective study Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010
Risk factors of febrile neutropenia induced by chemotherapy in lung cancer patients Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016
Microbiology in lung cancer febrile neutropenia. Multicentric retrospective study Source: Annual Congress 2008 - Treatment of thoracic tumours Year: 2008
Febrile episodes without leukopenia are more important for survival than febrile leukopenia in lung cancer patients receiving chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 76s Year: 2005
Significance of febrile episode in patients with lung cancer during therapy - comparison of NSCLC and SCLC patients Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002
Efficacy and safety of amurubicin (AMR) for the elderly with refractory relapse small cell lung cancer (SCLC) who had previous treatment Source: Annual Congress 2010 - Treatment of lung cancer Year: 2010
Management of concomitant COPD in patients with lung cancer Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan Source: ERJ Open Res, 6 (2) 00184-2019; 10.1183/23120541.00184-2019 Year: 2020
Neutropenia in lung cancer cases after chemotherapy Source: Eur Respir J 2006; 28: Suppl. 50, 753s Year: 2006
Predictive role of MMP-2 genetic variants on severe hematologic toxicity of NSCLC patients treated with first-line, platinum-based chemotherapy Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011
Predictors of radiation-induced lung toxicity in patients with locally advanced non small cell lung cancer (NSCLC): a retrospective analysis Source: Annual Congress 2009 - Management of thoracic malignancies Year: 2009
A preliminary study on targeted therapies in advanced lung cancer patients Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009
Assessment of lung cancer related symptoms and chemotherapy related side effects in a group of patients with advanced lung cancer receiving palliative chemotherapy Source: Eur Respir J 2006; 28: Suppl. 50, 752s Year: 2006